Sara M. Elkashef: Researchers at KAIST have found a way to reprogram cancer cells into behaving like normal cells
Sara M. Elkashef, Head of Pharmacology Team at shared on LinkedIn:
“I just came across something that feels like science fiction: researchers at KAIST have found a way to reprogram cancer cells into behaving like normal cells. No harsh chemo, no destroying everything in sight—just flipping a molecular ‘switch’ to restore balance.
Using a ‘digital twin’ of gene networks, they reversed colon cancer cells back into normal-like cells in the lab. It’s early days—this has only been tested on cells and animals so far—but the idea opens the door to a completely new class of cancer treatments. Instead of killing cancer cells (and dealing with awful side effects), we could one day focus on restoring them to health.
There’s still a long way to go, but this approach could change how we think about cancer therapy—making it not only more effective but also kinder to the body.
What do you think? Does this give you hope for the future of cancer treatment?”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023